Ventyx Biosciences Inc [NASDAQ: VTYX] stock went on an upward path that rose over 18.95% on Thursday, amounting to a one-week price increase of more than 50.41%.
Over the last 12 months, VTYX stock dropped by -62.32%. The one-year Ventyx Biosciences Inc stock forecast points to a potential upside of 79.01. The average equity rating for VTYX stock is currently 1.67, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $129.52 million, with 71.16 million shares outstanding and 63.06 million shares in the current float. Compared to the average trading volume of 1.04M shares, VTYX stock reached a trading volume of 7979714 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Ventyx Biosciences Inc [VTYX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VTYX shares is $8.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VTYX stock is a recommendation set at 1.67. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for Ventyx Biosciences Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on March 12, 2024. The new note on the price target was released on March 12, 2024, representing the official price target for Ventyx Biosciences Inc stock. Previously, the target price had yet another drop from $77 to $8, while Wells Fargo kept a Equal Weight rating on VTYX stock.
The Average True Range (ATR) for Ventyx Biosciences Inc is set at 0.16 The Price to Book ratio for the last quarter was 0.56, with the Price to Cash per share for the same quarter was set at 3.22.
VTYX Stock Performance Analysis:
Ventyx Biosciences Inc [VTYX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 50.41. With this latest performance, VTYX shares gained by 56.90% in over the last four-week period, additionally plugging by 2.82% over the last 6 months – not to mention a drop of -62.32% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VTYX stock in for the last two-week period is set at 73.51, with the RSI for the last a single of trading hit 79.58, and the three-weeks RSI is set at 67.90 for Ventyx Biosciences Inc [VTYX]. The present Moving Average for the last 50 days of trading for this stock 1.2299, while it was recorded at 1.5580 for the last single week of trading, and 1.8843 for the last 200 days.
Insight into Ventyx Biosciences Inc Fundamentals:
Ventyx Biosciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 19.57 and a Current Ratio set at 19.57.
VTYX Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VTYX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Ventyx Biosciences Inc go to 1.46%.
Ventyx Biosciences Inc [VTYX] Institutonal Ownership Details
The top three institutional holders of VTYX stocks are: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with ownership of 5.83 million shares, which is approximately 8.2625%. CITADEL ADVISORS LLC, holding 5.76 million shares of the stock with an approximate value of $$13.3 million in VTYX stocks shares; and CITADEL ADVISORS LLC, currently with $$12.12 million in VTYX stock with ownership which is approximately 7.4377%.
